• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深入蛋白质药物的核心——通过质谱法进行全面结构分析

Getting to the core of protein pharmaceuticals--Comprehensive structure analysis by mass spectrometry.

作者信息

Leurs Ulrike, Mistarz Ulrik H, Rand Kasper D

机构信息

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.

出版信息

Eur J Pharm Biopharm. 2015 Jun;93:95-109. doi: 10.1016/j.ejpb.2015.03.012. Epub 2015 Mar 17.

DOI:10.1016/j.ejpb.2015.03.012
PMID:25791210
Abstract

Protein pharmaceuticals are the fastest growing class of novel therapeutic agents, and have been a major research and development focus in the (bio)pharmaceutical industry. Due to their large size and structural diversity, biopharmaceuticals represent a formidable challenge regarding analysis and characterization compared to traditional small molecule drugs. Any changes to the primary, secondary, tertiary or quaternary structure of a protein can potentially impact its function, efficacy and safety. The analysis and characterization of (structural) protein heterogeneity is therefore of utmost importance. Mass spectrometry has evolved as a powerful tool for the characterization of both primary and higher order structures of protein pharmaceuticals. Furthermore, the chemical and physical stability of protein drugs, as well as their pharmacokinetics are nowadays routinely determined by mass spectrometry. Here we review current techniques in primary, secondary and tertiary structure analysis of proteins by mass spectrometry. An overview of established top-down and bottom-up protein analyses will be given, and in particular the use of advanced technologies such as hydrogen/deuterium exchange mass spectrometry (HDX-MS) for higher-order structure analysis will be discussed. Modification and degradation pathways of protein drugs and their detection by mass spectrometry will be described, as well as the growing use of mass spectrometry to assist protein design and biopharmaceutical development.

摘要

蛋白质药物是新型治疗剂中增长最快的类别,并且一直是(生物)制药行业主要的研发重点。由于其尺寸大且结构多样,与传统小分子药物相比,生物制药在分析和表征方面面临巨大挑战。蛋白质的一级、二级、三级或四级结构的任何变化都可能潜在地影响其功能、功效和安全性。因此,(结构)蛋白质异质性的分析和表征至关重要。质谱已发展成为表征蛋白质药物一级和高级结构的强大工具。此外,蛋白质药物的化学和物理稳定性以及它们的药代动力学如今通常通过质谱来确定。在此,我们综述了通过质谱分析蛋白质一级、二级和三级结构的当前技术。将给出已确立的自上而下和自下而上蛋白质分析的概述,尤其将讨论使用诸如氢/氘交换质谱(HDX-MS)等先进技术进行高级结构分析。将描述蛋白质药物的修饰和降解途径及其通过质谱的检测,以及质谱在辅助蛋白质设计和生物制药开发方面日益增加的应用。

相似文献

1
Getting to the core of protein pharmaceuticals--Comprehensive structure analysis by mass spectrometry.深入蛋白质药物的核心——通过质谱法进行全面结构分析
Eur J Pharm Biopharm. 2015 Jun;93:95-109. doi: 10.1016/j.ejpb.2015.03.012. Epub 2015 Mar 17.
2
[Utilization of Hydrogen/Deuterium Exchange in Biopharmaceutical Industry].[氢/氘交换在生物制药行业中的应用]
Klin Onkol. 2016 Fall;29 Suppl 4(Suppl 4):59-63.
3
Higher order structure characterization of protein therapeutics by hydrogen/deuterium exchange mass spectrometry.通过氢/氘交换质谱法对蛋白质治疗药物的高级结构进行表征
Anal Bioanal Chem. 2014 Oct;406(26):6541-58. doi: 10.1007/s00216-014-7924-3. Epub 2014 Jun 20.
4
Measuring the hydrogen/deuterium exchange of proteins at high spatial resolution by mass spectrometry: overcoming gas-phase hydrogen/deuterium scrambling.通过质谱法高空间分辨率测量蛋白质的氢/氘交换:克服气相氢/氘重排。
Acc Chem Res. 2014 Oct 21;47(10):3018-27. doi: 10.1021/ar500194w. Epub 2014 Aug 29.
5
Top-down mass spectrometry and hydrogen/deuterium exchange for comprehensive structural characterization of interferons: implications for biosimilars.基于自上而下的质谱法和氢/氘交换技术对干扰素进行全面结构表征:对生物类似药的影响。
Proteomics. 2014 May;14(10):1249-58. doi: 10.1002/pmic.201300341. Epub 2014 Apr 10.
6
Technical decision making with higher order structure data: utilization of differential scanning calorimetry to elucidate critical protein structural changes resulting from oxidation.基于高阶结构数据的技术决策:利用差示扫描量热法阐明氧化导致的关键蛋白质结构变化。
J Pharm Sci. 2015 Apr;104(4):1548-54. doi: 10.1002/jps.24313. Epub 2015 Jan 5.
7
Structural mass spectrometry in biologics discovery: advances and future trends.结构质谱在生物制剂发现中的应用:进展与未来趋势。
Drug Discov Today. 2012 Dec;17(23-24):1323-30. doi: 10.1016/j.drudis.2012.07.006. Epub 2012 Jul 20.
8
The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.氢/氘交换质谱在生物制药可比性研究中的应用。
J Pharm Sci. 2011 Jun;100(6):2071-86. doi: 10.1002/jps.22432. Epub 2010 Dec 29.
9
Analytical lessons learned from selected therapeutic protein drug comparability studies.从选定的治疗性蛋白质药物可比性研究中汲取的分析经验教训。
Biologicals. 2013 May;41(3):131-47. doi: 10.1016/j.biologicals.2012.10.001. Epub 2012 Nov 10.
10
Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development - A review.生物制药发现与开发中的氢氘交换质谱法——综述
Anal Chim Acta. 2016 Oct 12;940:8-20. doi: 10.1016/j.aca.2016.08.006. Epub 2016 Aug 9.

引用本文的文献

1
Analytical approaches for assessing protein structure in protein-rich food: A comprehensive review.评估富含蛋白质食物中蛋白质结构的分析方法:全面综述。
Food Chem X. 2024 Apr 8;22:101365. doi: 10.1016/j.fochx.2024.101365. eCollection 2024 Jun 30.
2
Comparative Study of SERS-Spectra of NQ21 Peptide on Silver Particles and in Gold-Coated "Nanovoids".银胶和金包“纳米空穴”中 NQ21 肽的 SERS 光谱对比研究
Biosensors (Basel). 2023 Sep 20;13(9):895. doi: 10.3390/bios13090895.
3
Chromatography at -30 °C for Reduced Back-Exchange, Reduced Carryover, and Improved Dynamic Range for Hydrogen-Deuterium Exchange Mass Spectrometry.
在-30°C 下进行色谱分离,可减少氢氘交换质谱法中的反向交换、携带污染并提高动态范围。
J Am Soc Mass Spectrom. 2022 Jul 6;33(7):1282-1292. doi: 10.1021/jasms.2c00096. Epub 2022 Jun 22.
4
SOMSpec as a General Purpose Validated Self-Organising Map Tool for Rapid Protein Secondary Structure Prediction From Infrared Absorbance Data.SOMSpec作为一种通用的经过验证的自组织映射工具,用于从红外吸收数据快速预测蛋白质二级结构。
Front Chem. 2022 Jan 27;9:784625. doi: 10.3389/fchem.2021.784625. eCollection 2021.
5
Is Protein Folding a Thermodynamically Unfavorable, Active, Energy-Dependent Process?蛋白质折叠是一个热力学不利的、主动的、依赖能量的过程吗?
Int J Mol Sci. 2022 Jan 4;23(1):521. doi: 10.3390/ijms23010521.
6
Advances in Hydrogen/Deuterium Exchange Mass Spectrometry and the Pursuit of Challenging Biological Systems.氢/氘交换质谱技术的进展及对挑战性生物系统的探索。
Chem Rev. 2022 Apr 27;122(8):7562-7623. doi: 10.1021/acs.chemrev.1c00279. Epub 2021 Sep 7.
7
Detection of structural and conformational changes in ALS-causing mutant profilin-1 with hydrogen/deuterium exchange mass spectrometry and bioinformatics techniques.使用氢/氘交换质谱和生物信息学技术检测 ALS 致病突变原纤维蛋白-1 的结构和构象变化。
Metab Brain Dis. 2022 Jan;37(1):229-241. doi: 10.1007/s11011-021-00763-y. Epub 2021 Jul 24.
8
Characterization and Quantification of an Fc-FGF21 Fusion Protein in Rat Serum Using Immunoaffinity LC-MS.采用免疫亲和 LC-MS 法对大鼠血清中的 Fc-FGF21 融合蛋白进行鉴定和定量分析。
AAPS J. 2019 Jul 8;21(5):84. doi: 10.1208/s12248-019-0356-4.
9
Interlaboratory Comparison of Hydrogen-Deuterium Exchange Mass Spectrometry Measurements of the Fab Fragment of NISTmAb.NISTmAb 抗体 Fab 片段的氢氘交换质谱测量的实验室间比较
Anal Chem. 2019 Jun 4;91(11):7336-7345. doi: 10.1021/acs.analchem.9b01100. Epub 2019 May 14.
10
The NISTmAb tryptic peptide spectral library for monoclonal antibody characterization.NISTmAb 酶切肽谱库用于单克隆抗体表征。
MAbs. 2018 Apr;10(3):354-369. doi: 10.1080/19420862.2018.1436921. Epub 2018 Mar 6.